Defunct Company
Total Trials
7
As Lead Sponsor
0
As Collaborator
Total Enrollment
2,163
NCT01952678
Compare Rates of Agreement Between Clinical Diagnosis and Visual Assessment of DaTscan™ Images in Non-Caucasian and Caucasian Subjects With Parkinson's Disease (PD) or Essential Tremor (ET)
Phase: N/A
Role: Collaborator
Start: Jul 30, 2013
Completion: May 31, 2016
NCT01936649
Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.
Phase: Phase 4
Start: Aug 31, 2013
Completion: Feb 28, 2014
NCT02090855
Re-Read Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Neuritic Plaque Density Determined Postmortem
Start: Sep 30, 2013
NCT02127307
Phase 4 Study to Demonstrate Prognostic Usefulness of AdreView™ Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience Death During 60 Months Follow-up.
Start: Feb 28, 2014
Completion: Apr 30, 2016
NCT02349386
Maintaining Suppression of Testosterone With Transdermal Estradiol Gel
Phase: Phase 2
Start: Jul 31, 2015
Completion: Jan 10, 2018
NCT02656329
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
Phase: Phase 3
Start: Dec 30, 2015
Completion: May 4, 2018